GlassScriptPhysician profile
Pamela Gordon
NPI 1669463097
$1,153.81
in general payments reported to CMS, 2019-2025
16 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.66 · 2021: $61.69 · 2022: $689 · 2023: $168 · 2024: $15.89 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $252.95 | 2021-2023 | Prolia, Evenity |
| Novo Nordisk INC | $197.00 | 2022-2023 | |
| Abbvie INC. | $133.89 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $128.20 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $121.25 | 2022-2023 | Eliquis |
| Pfizer INC. | $71.23 | 2022-2023 | |
| Irhythm Technologies, INC. | $49.66 | 2019 | |
| Viiv Healthcare Company | $43.68 | 2025 | Apretude |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.36 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.44 | 2022 | |
| Braeburn INC. | $17.83 | 2025 | Brixadi |
| Shield Therapeutics INC | $16.83 | 2023 | Accrufer |
| Dynavax Technologies Corporation | $16.77 | 2022 | |
| Hologic Sales and Service, LLC | $15.89 | 2024 | Aptima |
| Daiichi Sankyo INC. | $15.77 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.